Research


Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther Kim, Journal of Investment Management 14(2016), 87–101.

View abstract

Hedge fund holdings and stock market efficiency

with Charles Cao, Bing Liang, and Lubomir Petrasek, Review of Asset Pricing Studies, 2017, forthcoming

View abstract

Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology

with Vahid Montazerhodjat; Shomesh E. Chaudhuri; Daniel J. Sargent, JAMA Oncology (2017)

View abstract

Health, Wealth, and the 21st Century Cures Act

with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.

View abstract

TRC Networks and Systemic Risk

with Roger Stein, Journal of Alternative Investment 18(2016), 52–67.

View abstract

The Wisdom of Twitter Crowds: Predicting Stock Market Reactions to FOMC Meetings via Twitter Feeds

with with Pablo D. Azar, Journal of Portfolio Management 42(2016), 123–134.

View abstract

Q Group Panel Discussion: Looking to the Future

with Martin Leibowitz, Robert C. Merton, Stephen A. Ross, and Jeremy Siegel, Financial Analysts Journal

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

What Is An Index?

Journal of Portfolio Management 42(2016), 21–36.

View abstract

Law Is Code: A Software Engineering Approach to Analyzing the United States Code

with William Li, Pablo Azar, David Larochelle, Phil Hill, Journal of Business & Technology Law 10(2015), 297–374.

View abstract


Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design